Kobayashi Pharmaceutical Co(JP:4967)
¥6,931.00-72.00 (-1.03%)
JP:4967
Kobayashi Pharmaceutical Co Revenue
¥6,931.00
At close:-72.00 (-1.03%)
Want to see JP:4967 full AI Analyst Report?
Kobayashi Pharmaceutical Co (4967) Revenue
0 Followers
Kobayashi Pharmaceutical Co Revenue
Kobayashi Pharmaceutical Co had a revenue of 37.08B in the quarter ending Jun 30, 2026, with 10.16%. This bring the company's revenue in the last twelve months to 167.47B, Increased 0.40%. In the fiscal year ending Dec 31, 2025, Kobayashi Pharmaceutical Co had annual revenue of 165.74B with 0.09% growth.
- Revenue (ttm)
- 167.47B
- Revenue Growth
- 2.46%
- P/S Ratio
- 3.13
- Revenue/Employee
- JPY 44,422,943
- Employees
- 3,731
- Market Cap
- JPY 519.36B
Revenue Chart
Kobayashi Pharmaceutical Co Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 165.74B | 142.00M | 0.09% |
| Dec 31, 2024 | 165.60B | -7.86B | -4.53% |
| Dec 31, 2023 | 173.46B | 7.20B | 4.33% |
| Dec 31, 2022 | 166.26B | 11.01B | 7.09% |
| Dec 31, 2021 | 155.25B | 4.74B | 3.15% |
| Dec 31, 2020 | 150.51B | -17.54B | -10.44% |
| Dec 31, 2019 | 168.05B | 573.00M | 0.34% |
| Dec 31, 2018 | 167.48B | 10.72B | 6.84% |
| Dec 31, 2017 | 156.76B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.